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OObjective: Theory and guidelines advocating the inclusion of informal
care in economic evaluation have, in recent years, been accompanied
by developments in themethods for capturing the costs and outcomes
related to informal care. The objective of this study was to review ap-
plied economic evaluations to identify the methods used for, and im-
plications of, including informal care in practice.Methods: Searches of
ey databases were conducted to identify all full economic evaluations
ncorporating costs or outcomes relating to informal care. Information
as extracted by using a standard template from all studies meeting
he inclusion criteria. Results: Thirty economic evaluationswere iden-
ified that included informal care. Twenty-five of these studies costed
arers’ time input and 17 measured outcomes for carers. The reported
ost-effectiveness of interventions was altered by including informal
are, in some cases changing the key conclusions for health care
Unit,
.
al So
ttp://dx.doi.org/10.1016/j.jval.2012.05.009unding. Conclusions: Theory and methods development around in-
ormal care are yet to significantly permeate the applied literature;
owever, the results suggest that some funding priorities may change
f they were to do so. The development of 1) a reference case for includ-
ng informal care; 2) sensitivity analysis for contentious issues; and 3) a
tatement for the reason for excluding informal care, if this is deemed
ppropriate, may help to improve the way that informal care is in-
luded in economic evaluations in the future.
eywords: economic evaluation, indirect costs, informal care, outcome
easurement, review.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Informal carers have an important, yet ambiguous, role in eco-
nomic evaluation [1]. The time spent providing informal care (such
as personal care andhousehold tasks) is a resource that is usedup as
a result of an illness, and so carers should arguably be considered as
a cost in economic evaluation. The carer’s quality of life, however,
may also be affected by a patient’s illness, the caring tasks, or health
care intervention, and so outcomes for carersmay also be relevant in
an economic evaluation. If a health care intervention improves the
quality of life of the carer or reduces the time the carer need to spend
caring, then economic evaluations that ignore informal care will un-
derestimate the value of the intervention. When the economic eval-
uation is designed to inform decisions on the amount of health care
funding, then ignoring informal carewill lead toanunderinvestment
in health care. Conversely, if the economic evaluation is designed to
inform resource allocation decisionswithin a fixed budget for health
care, then ignoring informal care will lead to a relative underinvest-
ment in those interventions that benefit carers [2].
For certain conditions, carers’ time input may be substantial
[3,4]. In economic evaluations where individuals’ time use is con-
sidered an important resource (usually those evaluations that take
a “societal perspective”), time needs to be measured and valued.
Measurement and valuation of time is a contentious issue. Carers
* Address correspondence to: Hareth Al-Janabi, Health Economics
am, Public Health Building, Edgbaston, Birmingham B15 2TT, UK
E-mail: h.aljanabi@bham.ac.uk.
098-3015/$36.00 – see front matter Copyright © 2012, Internation
ublished by Elsevier Inc.may engage in joint production [5]; for example, they may use
their time to carry out additional housework resulting from a pa-
tient’s illness (which may be considered informal care), while en-
gaging in leisure, for example, watching television. There is also
debate as to whether foregone work time represents a significant
loss in “value” to society. Proponents of the friction cost view of
productivity losses argue that someone else who is not currently
employed is likely to take up the job of an individual when he or
she leaves the labor market. As a consequence, the net social loss
of foregone employment, due to disease or caring, for example, is
smaller than would be assumed under a human capital approach
[6]. This is especially the case when unemployment and/or labor
market flexibility is high. Because informal care, by definition,
does not normally involve monetarily compensated tasks, non-
market techniques are required to value the time spent on infor-
mal care. The two main methods use the price of an equivalent
service (the proxy good method) or the value of the carer’s fore-
gone activity (the opportunity costmethod) [7]. Valuations derived
by using a single proxy good or opportunity cost may mask indi-
vidual differences in the value different carers place on their time
and ignore the value of the relationship between carer and recip-
ient. As a result, a series of studies have also used stated prefer-
ence techniques, such as contingent valuation and discrete choice
experiments, to understand how much carers would need to be
compensated to provide more care in specific situations [8–11].
School of Health and Population Sciences, University of Birming-
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
l
c
c
e
p
b
s
c
f
s
p
e
E
m
e
c
t
e
u
c
d
976 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 9 7 5 – 9 8 1There is growing evidence demonstrating that the provision of
informal care can affect the quality of life of carers. Caring has been
associated with an increased risk of mortality [12], psychiatric mor-
bidity [13], and complex well-being effects, both positive and nega-
tive [14–17]. The quality-of-life impacts on carers arise both from the
anxiety over a loved one’s health and the potentially fulfilling, but
often stressful, nature of providing care. A broad array of outcome
measures designed for usewith carers are available [18]. Thesemea-
sures typically comprise items tomeasureproblems inhealth, family
life, and social life, but for economic evaluation, somemeasureof the
value of change on themeasures is required and this is rarely incor-
porated. The diverse quality-of-life impacts on carers can potentially
be captured for economic evaluations by using generic health-re-
lated quality-of-life measures [19,20] or preference-based “care-re-
ated” quality-of-life measures [21,22]. Double counting may be a
oncernwhen informal care is incorporated as both an outcome and
ost [23,24], as carers may, in theory, consider time sacrifices when
xpressing changes in their quality of life.
Alongsidemethodological development in techniques to incor-
orate informal care in economic evaluation, policymakers are
eginning to acknowledge the importance, and the need, to con-
ider informal care in policy decisions [25]. A growing number of
ountries are adopting economic evaluation as amethod to inform
unding decisions, with around half recommending a societal per-
pective in economic evaluation and three quarter a health care
erspective [26]. Notably, both the influential US panel on cost-
ffectiveness and the UKNational Institute for Health and Clinical
xcellence advise analysts to consider health impacts on family
embers and carers [27,28].
Given the calls for informal care to be given prominence in
conomic evaluations, it is pertinent to examine whether these
alls have been heeded. The aim of this study was to investigate
hree related research questions to inform this issue: 1) To what
xtent has informal care been included in applied economic eval-
ation? 2) How consistent are the methods for including informal
are? and 3) To what degree does including informal care make a
ifference to the inferences drawn from the economic evaluation?
Methods
A review of applied economic evaluations was conducted to ex-
plore the three research questions stated in the previous section.
Inclusion criteria was set in advance, with studies being included
only if they 1) were full economic evaluations; 2) incorporated
costs and/or outcomes related to informal care, describing the
methods for doing so; and 3) were written in English.
Search Strategy
MEDLINE (OVID), EMBASE (OVID), NHSEED (CRD), CINAHL (EBSCO),
ERIC (PROQUEST), PsycInfo (OVID), EconLit (EBSCO), and Web of
Science (ISI) were searched for studies between 1950 and 2010.
ERIC covered both published and nonpublished literature. A Bool-
ean strategy was used for the search in which a keyword relating
to informal care was combined with a keyword relating to eco-
nomic evaluations (Table 1). Where appropriate, an asterisk was
used to capture all possible variations of the stem word. All possi-
ble combinations were used in each database, with the exception
of NHSEED (because NHSEED contains only health-related eco-
nomic evaluations, keywords relating only to informal care were
used). The search was expanded to include all areas of the article,
including the full text, because it was possible that an economic
evaluation incorporated informal care despite not describing that
fact in the keywords or the abstract. The list of study titleswas also
supplemented with potentially relevant economic evaluations al-
ready known to the study authors.Study Selection
Following deletion of duplicates, the study selection occurred in
two phases, first based on the titles and abstracts and then based
on the full texts. In the first phase of the study selection, studies
were excluded as not relevant if they were not published in Eng-
lish, descriptive studies (not full economic evaluations), and/or
studies in which the costs and outcomes were detailed in the ab-
stract and clearly did not include informal care. Where there was
ambiguity, the studywas retained. Full articleswere then obtained
for the second phase of study selection, and studieswere excluded
at this stage if they did not incorporate informal care as a cost or
outcome, did not differentiate between formal and informal care,
or provided no details as to how informal costs and/or outcomes
were incorporated in the economic evaluation. Country of origin,
disease area, perspective, and type of economic evaluation were
not, however, used as exclusion criteria.
To investigate reliability of the study selection, selection was
performed by all three authors on a random sample of 5% of the
studies by using the exclusion criteria described above. The
overall agreement was then calculated by using Cohen’s kappa
statistic [59].
Data Extraction
A data extraction form was developed to extract the relevant in-
formation from the studies selected. To identify the characteris-
tics of studies incorporating informal care, information was ex-
tracted from all studies on the publication year, study country,
disease area, intervention, perspective, type of economic evalua-
tion, use of sensitivity analysis, and the impact of incorporating
informal care on the results of the economic evaluation.
Results
Study Selection
The review was performed in June 2010. In total, 5967 potential
studies were identified (5849 were derived from the database
search, 106 from hand-searching the references and citations of
key articles, and 12 from the study authors). Following the removal
of duplicates, 2282 studies remained. All three study authors re-
viewed a subsample of 114 randomly selected abstracts. The
chance-corrected agreement between the abstracts selected by
the primary author and the two coauthors was in the range of 0.79
and 0.9, or “almost perfect” [60]. Discrepancies were resolved
through discussion between the authors as to how the study char-
acteristics of the disputed studies related to the inclusion criteria.
Table 1 – Keywords used in the search.
Keywords relating to
informal care
Keywords relating to
economic evaluations
Caregive* Cost-benefit analysis
Carer Cost-effectiveness analysis
Family carer Cost-utility analysis
Home carer Economic evaluation
Informal care*
Informal caregive*
Unpaid care*
Note. Search in MEDLINE.
[caregive* OR carerOR family carer ORhome carerOR Informal care*
OR Informal caregive* OR unpaid care*] AND [cost-benefit analysis
OR cost-effectiveness analysis OR cost-utility analysis OR economic
evaluation].Disagreement occurred only on a tiny fraction of abstracts. The
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been retained clarified the protocol for including and excluding
studies for the remainder of the sample. In view of this clarifica-
tion and the high interrater agreement, a single individual (the
primary author) reviewed the remainder of the study abstracts. In
the first phase of the study selection, 1792 studies were excluded
on the basis of titles and abstracts, leaving 484 articles for the
second phase of the study selection. Of these, a further 132 were
not full economic evaluations and 261 did not incorporate infor-
mal care, and so were removed. Finally, 61 studies were full eco-
nomic evaluations that incorporated informal care, but the valu-
ation method was not described or informal care was not
considered as a separate entity from formal care. To ensure that
the review would be informative in terms of how informal care
was incorporated in economic evaluation, these studies were ex-
cluded. This left 30 studies that met the criteria for this review.
Characteristics of Studies Incorporating Informal Care
The characteristics of the 30 economic evaluations included in this
review are presented in Table 2. The United Kingdom was the
ountry where most studies were conducted, although studies
ere also conducted elsewhere in Europe and in North America,
sia, Africa, and Australia.
The studies evaluated a wide range of interventions, with the
ajority being interventions targeted at patients (such as drugs
29,30,37,39,43,47,52,53,58] and vaccinations [31,42,48]). Ten stud-
es, however, evaluated interventions that clearly targeted carers.
hese included interventions where carers and patients were
ointly targeted [32] and oneswhere carerswere the primary target
including training [50] and befriending [57]). Just over half of all
he studies were in the field ofmental and behavioral disorders (of
hich 11 looked at interventions for dementia [35–37,39–
1,44,47,49,57,58]. In addition, two studies covered mixed popula-
ions of old or chronically ill individuals that were likely to include
are of individuals with mental health problems [32,34]. Of the
emaining 12 studies, 4 related to infectious diseases, 4 to cardio-
ascular diseases, 2 to diseases of the eye, 1 to respiratory disease,
nd 1 to cancer.
Despite the search covering a period of 60 years, only five stud-
es were published prior to 2000. Of the remaining 25 studies, 10
ere published between 2000 and 2005 and 15 between 2006 and
010. Studies published since 2006 were twice as likely (10 of 15) to
se cost-utility analysis than those published in 2005 or earlier (5
f 15). Two thirds of the studies adopted a “societal” perspective,
ither exclusively or in addition to a narrower “payer” perspective.
f the remaining studies, eight studies adopted a purely payer
ealth care perspective and two studies adopted a “carer” perspec-
ive.
Methods of Incorporating Informal Care
Overall, 13 studies incorporated informal care as a cost only, 12
studies incorporated informal care as both a cost and outcome,
and the remaining 5 incorporated only outcomes of the interven-
tion for carers. The decision about how to incorporate informal
care in the economic evaluation appears to be driven by the per-
spective taken and the nature of the intervention. Of those studies
that adopted a societal perspective, all 20 incorporated informal
care costs, whereas of the 10 that did not, only 5 did. Of those
studies that looked at patient-focused interventions, 7 of the 20
studies considered outcomes for carers. Of the studies that looked
at interventions for carers, 9 of the 10 studies considered out-
comes for carers.
The first step in incorporating informal care costs is to estimate
the time spent on informal care. In measuring carers’ time input,
there was no obvious attempt in any study to identify whether
other activities, such as regular housework or leisure, were under-taken at the same time as informal care (joint production). In re-
ality, joint production probably occurred for some carers in each
study, at least some of the time. Because no correction was made
to allow for this (e.g., using a technique, such as that outlined by
Van Den Berg [61]), it is possible that estimates of informal care
time were generally inflated. Most of the studies that stated how
carers’ time input was estimated used a recall questionnaire. Only
a few studies used carer diaries [30,36,53–55], although these were
often more recent studies. Both the opportunity cost method and
the proxy goodmethodwere used to value carers’ time inputs (the
formerwasmore popular).Within each valuationmethod, a range
of assumptions were employed about the appropriate proxy price
or opportunity cost.When timewas valued by using a proxy, stud-
ies used either thewage of a paid carer [37,45,47,49,51) or thewage
of a cleaner [40,41,52,56), irrespective of what informal care was
undertaken. For studies that valued time by using the opportunity
cost method, it was typically assumed that the carer had given up
paid work to provide care and the studies variously used the aver-
age wage rate [29,30,37,43,47,57,54,55), minimum wage rate
[36,39,45,46,50,51,53], actual wage of the carer [31,42], or wages of
matched individuals [33] to value this time.
Of the 17 studies that incorporated outcomes for carers, 8 used
generic health status measures (the EuroQol five-dimensional
questionnaire, health utilities index, SF-6D [derived from short
form 36 health survey]) and calculated quality-adjusted life-years
(QALYs) for carers. In the remaining studies, a number of mea-
sures were used. Three studies used carer-specific measures of
quality of life as their primary outcome; these were the Caregiver
Quality of Life Instrument [35], the Caregiver Strain Index [38], and
the Sense of Competence Questionnaire [41]. While the latter two
measures provide only an unweighted score, the Caregiver Quality
of Life Instrument was used to generate “care-related” QALY esti-
mates for carers. Of the remaining studies, two used measures of
carers’ free time [40,49], two used willingness to pay [47,58], and
two used amix of clinical questionnaires on health, hope, morale,
and satisfaction [32,34] as outcomemeasures. Outcomes for carers
and patients were summed together, in either the base-case or
sensitivity analysis, on six occasions [31,39,42,47,48, 57]. In the
remaining studies, patient outcomes were either not considered
or were calculated by using a different outcomemeasure and pre-
sented alongside carer outcomes in a disaggregated format.
Impact of Informal Care on Cost-Effectiveness
With such a variety of techniques available, one may argue that
the impact of the method of incorporating informal care on the
final cost-effectiveness estimate should be explored in the sensi-
tivity analysis. In terms of costing, three studies valued carers’
time by using both the proxy good and opportunity cost methods
[37,45,51]. In one study, the average of the techniques was used as
the value in the main analysis [37]. In the other two studies, the
sensitivity analysis revealed that the valuation technique had a
considerable impact on the magnitude of costs without changing
the inference about the most cost-effective alternative. In one
study looking at cognitive behavioral therapy and exercise for
chronic fatigue syndrome [45], overall costs were swamped by the
time costs of informal care, but the pattern of these across the trial
arms did not alter the main conclusions about the relative cost-
effectiveness of the interventions. In the other study, looking at
stroke care strategies [51], informal care costs were again a large
proportion of overall costs. Although including informal care sig-
nificantly magnified the cost advantage of one intervention over
the other, this only served to make it look a more cost-effective
alternative than it previously appeared.
The inclusion of informal care per se did not lead to a clear
general effect on the cost-effectiveness of a new intervention.New
interventions tended to have a positive impact on the quality of
life of carers when this was measured. However, in terms of carer
Table 2 – Summary of the studies included in this review.
Author Country Perspective Method of
economic
evaluation
Clinical field Target:
patients or
carers?
Informal
care: cost or
outcome?
Valuation
method*
Agha et al. [29] United States Society CUA Cardiovascular Patients Cost OCM
Andersson et al. [30] Sweden Society CCA Respiratory Patients Cost OCM
Bilcke et al. [31] Belgium Payer and society CEA and CUA Infections Patients Both OCM and QALYs
Browne et al. [32] Canada Payer CCA Multiple Both Both OCM and SSM
Clark et al. [33] United States Society CEA Mental/behavioral Patients Cost OCM
Cummings et al. [34] United States Payer CCA Multiple Patients Outcome SSM
Drummond et al. [35] Canada Payer CUA Mental/behavioral Carers Outcome QALYs
Duff and Dolphin [36] Ireland and others Society CBA Mental/behavioral Carers Both OCM and WTP
Fuh and Wang [37] Taiwan Payer and society CUA Mental/behavioral Patients Cost OCM and PGM
Gage et al. [38] United Kingdom Payer CCA Mental/behavioral Carers Outcome SSM
Getsios et al. [39] United Kingdom Payer and society CUA Mental/behavioral Patient Both OCM and QALYs
Gitlin et al. [40] United States Other (carer) CEA Mental/behavioral Both Both PGM and SSM
Graff et al. [41] Netherlands Society CEA Mental/behavioral Carers Both PGM
Jit and Edmunds [42] United Kingdom Payer CUA Infections Patients Both OCM and QALYs
Lidgren et al. [43] Sweden Society CUA Cancer Patients Cost OCM
Martikainen et al. [44] Finland Payer CUA Mental/behavioral Carers Outcome QALYs
McCrone et al. [45] United Kingdom Society CEA Mental/behavioral Patients Cost PGM and OCM
Moalosi et al. [46] Botswana Payer and society CEA Infections Patient Cost OCM
Neumann et al. [47] United States Societal CUA Mental/behavioral Patient Both PGM and QALYs
Newall et al. [48] Australia Payer and society CEA and CUA Infections Patients Both OCM and QALYs
Nichols et al. [49] United States Society CEA Mental/behavioral Carers Both PGM
Patel et al. [50] United Kingdom Society CUA Cardiovascular Carers Both OCM
Patel et al. [51] United Kingdom Society CEA and CUA Cardiovascular Patients Cost PGM and OCM
Patel et al. [52] India Society CEA Mental/behavioral Patients Cost PGM
Romeo et al. [53] United Kingdom Society CEA Mental/behavioral Patients Cost OCM
Sach et al. [54] United Kingdom Payer CEA and CUA Eye Patients Cost OCM
Sach et al. [55] United Kingdom Payer CUA Eye Patients Cost OCM
van Heelvoort-Postulart et al. [56] Netherlands Society CUA Cardiovascular Patients Cost PGM
Wilson et al. [57] United Kingdom Society CUA Mental/behavioral Carers Both OCM and QALYs
Wu et al. [58] Canada Other (carer) CBA Mental/behavioral Patients Outcome WTP
CBA, cost-benefit analysis; CEA, cost-effectiveness analysis; CUA, cost-utility analysis; OCM, opportunity cost method; PGM, proxy good method; QALY, quality-adjusted life-year; SSM, sum score
measures; WTP, willingness to pay.
* Valuation methods: Costs: OCM, PGM; outcomes: QALYs, WTP, SSM not valued.
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979V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 9 7 5 – 9 8 1time, they were variously associated with a higher or lower time
input. As a result, while the effectiveness estimate of the interven-
tion tended to be inflated by including informal care, the cost-
effectiveness estimates could go either way. A number of studies
also provided information on a cost-per-QALY estimate both with
and without informal care [31,37,39,44,47,48,51,54,55,57]. In one
study, inclusion of informal care costs changed the inference
about a new intervention from cost-effective to dominant [37]. In
four of the remaining nine studies, the inclusion of informal care
had an impact on cost-effectiveness around the critical range,
such that the inference about themost cost-effective intervention
was altered [31,48,55,57]. Inclusion of carer outcomes in two of the
rotavirus studies resulted in an intervention looking much more
cost-effective than when the focus was only on patient outcomes
[31,48]. Conversely, including carer costs in a study of cataract
surgery resulted in the intervention looking, on balance, less cost-
effective than the comparator [55].
Discussion
This review found that a small proportion of applied economic
evaluations formally include informal care. Of those that do, the
vast majority consider the costs associated with informal care,
with just over half considering outcomes for carers. Even within
this small number of studies, there is huge heterogeneity in the
methods employed to incorporate informal care, with many dif-
ferent measurement and valuation techniques employed for both
costs and outcomes. It is clear that there is no consensus on how
informal care should be incorporated in economic evaluation. This
heterogeneity is mirrored by unpredictable impacts of including
informal care on the cost-effectiveness of interventions. In a num-
ber of studies, these impacts are sufficient to change the infer-
ences drawn as to whether the interventions should be funded.
Economic evaluations that do incorporate informal care are
concentrated in recent years, reflecting the increase in the body of
the literature generally, but perhaps also recent national guide-
lines advocating the inclusion of informal care. There is a clear
time lag between the design of a study and the publication of the
economic evaluation, and it is likely that methodological and the-
oretical work over the last 10 to 15 years will only recently be
reflected in techniques used in applied economic evaluations. To
some extent, this can be seenwith the increased use of cost-utility
analysis and diary methods to record carer time observed in this
study. In terms of clinical area, there was a clear dominance of
economic evaluations in mental health and in particular demen-
tia. Mental health problems often require the carer to deal with
mood and relationship changes, and this can be particularly diffi-
cult for familymembers [62,63] and likely to result in carers having
ealth problems of their own [13]. It is less clear, however, why no
conomic evaluations including informal care were identified in
ome other areas in which carers play an important role. Indi-
iduals with rheumatoid arthritis, for example, may require
arge amounts of informal care, and caring for these patients
ay result in poorer health for carers [64]. Similarly, multiple
clerosis can be a debilitating condition, requiring high levels of
upport in daily life from family members and friends [65]. Al-
though many economic evaluations of interventions in these
areas exist, none appear to have considered the use of, or im-
pacts on, informal carers.
Although care has been taken to include all relevant studies, it
should be noted that in the search for literature, some economic
evaluations that explicitly incorporated informal care may have
beenmissed. In the search, specific terms such as “economic eval-
uation” and “cost-effectiveness analysis” were used to identify
studies. Although more general terms have been proposed when
searching for economic evaluations, such as cost* or eco-
nomic*[66], in the context of this study (for economic evaluations cin all disease areas), these would have drastically increased the
number of potential abstracts. Thus, a decisionwasmade to go for
a search strategy thatwasmore specific. Thismayhave resulted in
the omission of studies that were in fact economic evaluations but
did not use any of the key words relating to economic evaluation
and were not registered on NHSEED.
Of the 30 studies reviewed, 25 considered informal care costs
and 17 considered outcomes to carers. This tendency toward in-
cluding informal care as a cost is, on one level, surprising. (Health)
outcomes for carers are compatible with a broader range of per-
spectives for economic evaluations. Whether an economic evalu-
ation takes a societal or a health care perspective, the objective is,
usually, to guide the decision-maker toward choices that maxi-
mize health gains from the resources available. Under a health
care perspective, however, the economic evaluation typically fo-
cuses on establishing themost efficient use (i.e., to promote health
or some other goal) of health care resources. These health care
resources are not normally taken to include carer (and patient)
time. The finding may reflect the view that an unpaid carer is
generally seen as an input to health (care) and thus is incorporated
in an economic evaluation as such. Further reasons that carers’
outcomes are rarely considered in economic evaluation may be
that they are perceived to 1) be unimportant, 2) lead to double
counting of carer costs, or 3) lead to double counting of patient
outcomes. In the case of 1), this review shows that even in areas
that one would not expect a priori for carer outcomes to be impor-
ant (e.g., rotavirus vaccination), carer outcomes can play a pivotal
ole when incremental costs are also low and there is large uncer-
ainty about themost cost-effective intervention. Whether carers’
utcomes are important in terms of cost-effectiveness is clearly an
mpirical question and seems deserving of more research across
ifferent clinical areas and decision problems. In the case of 2),
sing health-related quality-of-life measures and considering lei-
ure losses as an outcome is likely to minimize the possibility of
ouble counting [67]. There is, however, no evidence about poten-
ial double counting when using broader measures of outcome for
arers such aswillingness to pay or carer-related quality of life and
herefore, if informal care is to be regularly included in economic
valuation, this also represents an area of future investigation.
urning to 3), it is quite possible that quality-of-life changes for
arers may be directly attributable to changes in the patient
ealth, but it is also possible that they can be due to changes in the
aring role [68]. Whether or not such outcomes for carers consti-
ute double counting is a normative issue that has received little
iscussion in the literature.
A wide array of methods were used to incorporate informal
are in economic evaluations. These ranged in sophistication from
imple assumptions about time spent caring to the use of diaries
nd bespoke quality-of-life measures to calculate QALYs for car-
rs. The heterogeneity in methods is likely to be partly due to the
ack of consensus on the valuation of time and outcomes for carers
69]. On one hand, such inconsistency is concerning as the results
f economic evaluations are less comparable. On the other hand,
here is no unambiguous “right” way to cost informal care or value
he outcomes for carers in an extra-welfarist economic evaluation.
here are inherent normative issues that different countries and
gencies may take different stances on. The opportunity cost
ethod will value time losses for top earning carers more highly,
nd using this data could lead to distributional concerns that
ould worry some decision-making bodiesmore than others. Fur-
hermore, guidelines to ensure consistent methods on the inclu-
ion of informal care may reinforce methods for measuring out-
omes that are not wholly suitable. While QALYs calculated by
sing generic health status measures may be appropriate for pa-
ients, they are not necessarily appropriate for carers [2]. Measures
f care-related quality of lifemay bemore closely aligned to carers’
oncerns and more sensitive to intervention; however, such mea-
t
c
980 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 9 7 5 – 9 8 1sures are only starting to be used in applied studies. A compro-
mise, for now, may be to establish a reference case of methods for
the inclusion of informal care. This would supplement more gen-
eral guidelines on methods for incorporating informal care [5,24],
drawing on best practice where available (e.g., the use of diaries to
measure time spent on informal care [61] and valuation of leisure
time losses in terms of outcomes [70]), while allowing contentious
issues, such as the outcome measures used for carers or alterna-
tive valuation strategies, to be assessed through sensitivity anal-
ysis. Such a reference casewill need to be tailored to the individual
requirements of decision-makers. Separate reference cases are
likely to be neededwhen a societal perspective (where carers’ time
input is likely to be relevant) or a payer perspective (where just
health outcomes for carers may be relevant) are used. Two exam-
ples are presented in the appendix in Supplemental Materials
found at http://dx.doi.org/10.1016/j.jval.2012.05.009. These are not
intended to be exhaustive, and indeed quite different reference
cases would be needed if a welfarist view of the role of economic
evaluationwas taken. Although “Jurisdiction A” has similarities to
the (National Institute for Health and Clinical Excellence) guide-
lines for economic evaluation in England and “Jurisdiction B” to
guidelines for economic evaluation in the Netherlands [26], the
reference cases are intended to be illustrative only.
The impact of incorporating informal care in economic evalu-
ation varied from study to study. Incorporating informal care had
both a positive impact and a negative impact on the perceived
cost-effectiveness of a new intervention. In part this can be ex-
plained by the nature of the intervention, which, in some cases,
may need additional carer involvement [55], or, in other cases,
freed up the carer’s time through preventing [31] or delaying [39]
patient illness. The final cost-effectiveness inference rests not
only on the magnitude of informal care impacts but also on their
magnitude and direction relative to other costs and effects. A
greater understanding of how patient illness impacts on carers is
likely to be a useful first step to decide whether carer impacts a
priori are important. This information also needs to be considered
alongside the likely magnitude and direction of other outcomes
and costs (and, of course, in light of the perspective for the eco-
nomic evaluation and decision-maker’s requirements). While it
might not be feasible, or desirable, for all economic evaluations to
incorporate informal care, a clearer justification of the reason for
exclusion of informal care (if this is judged to be appropriate) would
promotemore transparency. Similarly, if informal care is incorpo-
rated, a short statement to explain themethods chosen (given the
wide array available) may also be useful.
Conclusion
Theory, guidelines, and methods to support the inclusion of
informal care do not appear to have permeated the applied eco-
nomic evaluation literature significantly to date. From the stud-
ies that have incorporated informal care, however, it appears
that excluding informal care would have altered cost-effective-
ness estimates, in some cases changing the key decision-mak-
ing inference drawn from the study. To improve the take-up and
consistency of methods, a specific reference case, covering the
costs and outcomes relevant to carers, for the most common
forms of economic evaluation may be useful. Where possible,
sensitivity analyses could be used to explore contentious valu-
ation issues on the cost and outcome side. Although including
informal care in every economic evaluation may not be feasible,
a simple first step would be for studies that exclude informal care
o justify their decision in terms of the irrelevance of informal
are to the decision problem.Acknowledgments
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